A detailed history of First Republic Investment Management, Inc. transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, First Republic Investment Management, Inc. holds 72,557 shares of TAK stock, worth $1.01 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
72,557
Previous 70,424 3.03%
Holding current value
$1.01 Million
Previous $1.11 Million 1.45%
% of portfolio
0.0%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 07, 2023

BUY
$15.03 - $16.32 $32,058 - $34,810
2,133 Added 3.03%
72,557 $1.12 Million
Q2 2023

Jul 28, 2023

SELL
$15.57 - $17.11 $80,154 - $88,082
-5,148 Reduced 6.81%
70,424 $1.11 Million
Q1 2023

May 11, 2023

BUY
$15.28 - $16.48 $162,579 - $175,347
10,640 Added 16.39%
75,572 $1.25 Million
Q4 2022

Feb 13, 2023

SELL
$12.42 - $15.62 $62,460 - $78,552
-5,029 Reduced 7.19%
64,932 $1.01 Million
Q3 2022

Nov 03, 2022

BUY
$12.8 - $28.65 $168,012 - $376,059
13,126 Added 23.09%
69,961 $907,000
Q2 2022

Aug 16, 2022

BUY
$13.12 - $15.03 $91,735 - $105,089
6,992 Added 14.03%
56,835 $798,000
Q1 2022

May 16, 2022

BUY
$13.54 - $15.35 $199,051 - $225,660
14,701 Added 41.83%
49,843 $714,000
Q4 2021

Feb 09, 2022

BUY
$13.17 - $16.4 $67,641 - $84,230
5,136 Added 17.12%
35,142 $479,000
Q3 2021

Nov 12, 2021

BUY
$16.3 - $17.26 $140,848 - $149,143
8,641 Added 40.44%
30,006 $491,000
Q2 2021

Aug 16, 2021

BUY
$16.55 - $18.64 $353,590 - $398,243
21,365 New
21,365 $360,000
Q1 2020

May 13, 2020

SELL
$13.02 - $20.31 $141,501 - $220,729
-10,868 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$16.88 - $20.83 $183,451 - $226,380
10,868 New
10,868 $214,000

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $43.3B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track First Republic Investment Management, Inc. Portfolio

Follow First Republic Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.